Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

46.340
-1.860-3.86%
Volume:8.35M
Turnover:397.21M
Market Cap:307.56B
PE:33.68
High:49.000
Open:48.300
Low:46.220
Close:48.200
52wk High:94.869
52wk Low:46.220
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:2.20
T/O Rate:3.24%
Dividend:0.23
Dividend Rate:0.50%
EPS(LYR):1.376
ROE:12.46%
ROA:7.02%
PB:4.09
PE(LYR):33.68
PS:8.42

Loading ...

Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop

Bulletin Express
·
Jun 25

Hengrui Pharma's Adebrelimab Injection Gains Approval for Additional NSCLC Perioperative Indication

Stock News
·
Jun 25

Jiangsu Hengrui Pharmaceuticals - Subsidiary Received Notification from Nmpa Approving New Indication for Adebrelimab Injection

THOMSON REUTERS
·
Jun 25

AH Share Premium and Deviation Rankings as of June 24th Close

Stock News
·
Jun 24

Movement Alert|Hengrui Medicine Rises 3.47% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Market Focus
·
Jun 24

Hengrui Pharma Withdraws Registration Application for Emaxitinib Ointment

Stock News
·
Jun 23

Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies

Stock News
·
Jun 23

European Drug Regulator Accepts Hengrui Pharma's Marketing Application for Revulutamide Tablets

MT Newswires Live
·
Jun 23

Movement Alert|Hengrui Medicine Rises 3.73% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Market Focus
·
Jun 23

Hengrui Pharma's Novel Drug Application for Rezvilutamide Accepted by European Regulator

Stock News
·
Jun 22

AH Premium and Deviation Data for June 22

Stock News
·
Jun 22

Movement Alert|Hengrui Medicine Falls 3.02% in Regular Trading, Broad Pharma Sector Sell-Off Amid Geopolitical Headwinds

Market Focus
·
Jun 22

AH Share Premium and Deviation Rankings as of June 18th

Stock News
·
Jun 18

Movement Alert|Hengrui Medicine Rises 3.02% in Regular Trading, Multiple Drug Approvals and Institutional Buying Boost Sentiment

Market Focus
·
Jun 18

Schroders Increases Stake in Hengrui Pharma by 948,800 Shares at HK$54.54 Per Share

Stock News
·
Jun 17

Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million

Bulletin Express
·
Jun 17

Hengrui Pharma Executes Share Buyback on June 17

Stock News
·
Jun 17

China Greenlights Clinical Trials for Two Hengrui Pharma Drugs, Approves Another Indication for Breast Cancer Drug

MT Newswires Live
·
Jun 17

Jiangsu Hengrui Pharmaceuticals - Received Notice From Nmpa New Indication for Dalpiciclib Isethionate Tablets, Cdk4/6 Inhibitor Approved

THOMSON REUTERS
·
Jun 16

HENGRUI PHARMA Receives Clinical Trial Approval for SHR-6914 Injection

Stock News
·
Jun 16